Retard metoprolol tartrate: effectiveness and safety in patients with Functional Class II-III stable effort angina

Retard metoprolol tartrate: effectiveness and safety in patients with Functional Class II-III stable effort angina

.

Saved in:

Bibliographic Details
Main Authors:	A. A. Kuprina, Yu. B. Belousov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2007-10-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2227
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
by: A. A. Anderzhanova, et al.
Published: (2016-01-01)

Metoprolol tartrate and succinate: from chemical structure to clinical effectiveness differences
by: Yu. B. Belousov, et al.
Published: (2007-06-01)

Dynamics of proinflammatory cytokines level in stable angina (II–III functional class)
by: E. K. Gordeeva, et al.
Published: (2016-09-01)

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)

Clinical and electrocardiographic markers of trimetazide effectiveness in patients with Functional Class II-III effort angina
by: Yu. N. Fedulaev, et al.
Published: (2007-06-01)

EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS
by: O. L. Barbarash, et al.
Published: (2016-01-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

GRAPHICAL REPRESENTATION OF THE CLINICAL OUTCOME OF ACUTE CORONARY SYNDROME INTO EFFORT ANGINA OF III FUNCTIONAL CLASS AT THE HOSPITAL LEVEL (PART II)
by: Marzhanat G. Alieva
Published: (2017-10-01)

TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
by: V. E. Oleinikov, et al.
Published: (2015-12-01)

Nitrates for angina episode prevention in patients with stable effort angina pectoris: what medications to choose?
by: A. L. Syrkin, et al.
Published: (2005-02-01)

THE USAGE OF METOPROLOL TARTRATE IN ELDERLY AND OLD PATIENTS WITH CORONARY HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE
by: E. B. Nagaytseva, et al.
Published: (2003-06-01)

Thermal transformations of bismuth (III) tartrates
by: Liubov I. Afonina, et al.
Published: (2022-08-01)

CORONARY ATHEROSCLEROSIS FACTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND METABOLIC SYNDROME
by: T. V. Krovyakova, et al.
Published: (2010-06-01)

Validation, measurement uncertainty estimation and evaluation of UHPLC greenness for simultaneous determination of metoprolol tartrate and hydrochlorothiazide in binary tablet
by: Claudia Vilela de Oliveira, et al.
Published: (2024-12-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

Antiischemic effects of metoprolol and the risk of carbohydrate metabolism disturbances in angina patients
by: E. V. Bochkareva, et al.
Published: (2012-12-01)

OBSTRUCTIVE SLEEP APNOEA SYNDROME IN PATIENTS WITH FUNCTIONAL CLASS IV EFFORT ANGINA
by: A. P. Goncharov, et al.
Published: (2010-02-01)

Carbohydrate metabolism parameters in angina patients treated with metoprolol and its combination with trimetazidine
by: E. V. Bochkareva, et al.
Published: (2012-08-01)

Lung function dynamics in smoking and non-smoking patients with stable effort angina, treated with beta-adrenoblockers
by: Yu. V. Lukina, et al.
Published: (2004-04-01)

Metoprolol retard effectiveness in patients with arterial hypertension and disturbed circadian blood pressure rhythm
by: P. P. Tikhonov, et al.
Published: (2006-08-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Central hemodynamics changes in patients with coronary heart disease, stable effort angina, treated with mildronate
by: M. V. Baluda, et al.
Published: (2007-08-01)

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-12-01)

Off-the-shelf medication transformed: Custom-dosed metoprolol tartrate tablets via semisolid extrusion additive manufacturing and the perception of this technique in a hospital context
by: Valerie R. Levine, et al.
Published: (2024-12-01)

Clinical-functional peculiarities of stable angina of different functional classes considering myocardial infarction in an anamnesis
by: V. K. Tashchuk, et al.
Published: (2020-12-01)

ANTIANGINAL AND ANTI2ISCHEMIC EFFECTIVENESS AND TOLERABILITY OF OXICARDIN IN PATIENTS WITH STABLE ANGINA OF I-III FUNCTIONAL CLASSES: RESULTS OF A RUSSIAN MULTICENTER RUSSIA
by: L. I. Olbinskaya, et al.
Published: (2002-10-01)

Metoprolol retard antihypertensive effectiveness in patients with mild to moderate arterial hypertension (multi-center study "Prolonger" results)
by: Yu. N. Sirenko, et al.
Published: (2006-04-01)

Effort angina pharmacotherapy in ambulatory practice
by: E. V. Gosteva
Published: (2008-06-01)

Monocinque clinical effectiveness in complex treatment of patients with chronic heart failure, functional class II-III angina, and chronic obstructive pulmonary disease
by: A. G. Evdokimova, et al.
Published: (2007-04-01)

USAGE OF OLICARD-40-RETARD IN TREATMENT OF PATIENTS WITH UNSTABLE ANGINA
by: A. L. Rakov, et al.
Published: (2001-02-01)

Clinical effectiveness and safety of shock wave therapy in patients with stable angina
by: Sh. Kh. Panaeva, et al.
Published: (2010-02-01)

Clinical and prognostic significance of C-reactive protein in the conditions of stable angina pectoris in combination with chronic obstructive pulmonary disease stage II–III
by: S. Ya. Dotsenko, et al.
Published: (2023-10-01)

METABOLIC PLATELET STATUS IN PATIENTS WITH STABLE ANGINA
by: I. Yu. Grinstein, et al.
Published: (2013-12-01)

GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS
Published: (2016-01-01)

CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA
by: A. Ya. Kravchenko, et al.
Published: (2016-01-01)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01)

Basic diagnostic criterions for effort angina on coronary angiography dates
by: A. I. Koryakov
Published: (2005-12-01)

GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (ENDING)
by: K. Fox, et al.
Published: (2015-12-01)

Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01)